These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 25816466)

  • 1. Actual to expected studies--Part 1.
    Wesley D; Cox H
    J Insur Med; 2014; 44(2):81-92. PubMed ID: 25816466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pivot tables for mortality analysis, or who needs life tables anyway?
    Wesley D; Cox HF
    J Insur Med; 2007; 39(3):167-73. PubMed ID: 18251375
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Actual to expected studies--Part 2.
    Wesley D; Cox H
    J Insur Med; 2014; 44(3):143-51. PubMed ID: 25622385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age dependent decline of relative risks in life insurance medical underwriting.
    Kneepkens RF; Lindeboom R
    J Insur Med; 2014; 44(3):170-83. PubMed ID: 25622389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum globulin predicts all-cause mortality for life insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2014; 44(2):93-8. PubMed ID: 25816467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life table analysis.
    Wesley D
    J Insur Med; 1998; 30(4):247-54. PubMed ID: 10537931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A method of relating life expectancy in the U.S. population life table to excess mortality.
    Singer RB
    J Insur Med; 1992; 24(1):32-41. PubMed ID: 10148475
    [No Abstract]   [Full Text] [Related]  

  • 8. The discipline of insurance medicine.
    Roberts NK
    J Insur Med; 1997; 29(2):79-81. PubMed ID: 10169634
    [No Abstract]   [Full Text] [Related]  

  • 9. Rating the raters: evaluating the predictions from a life expectancy rating service.
    Shavelle R; Strauss D
    J Insur Med; 2009; 41(3):178-90. PubMed ID: 20377097
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative mortality in cerebral palsy patients in California, 1980-1996.
    Singer RB; Strauss D; Shavelle R
    J Insur Med; 1998; 30(4):240-6. PubMed ID: 10537930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mortality from cerebrovascular disease. A study based on data from hospitalization benefits.
    Kobayashi M; Maeda M; Fujimoto H
    J Insur Med; 1995; 27(1):25-7. PubMed ID: 10158134
    [No Abstract]   [Full Text] [Related]  

  • 12. The derivation of life tables for local areas.
    Manuel DG; Goel V; Williams JI
    Chronic Dis Can; 1998; 19(2):52-6. PubMed ID: 9664025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NT-proBNP as a predictor of all-cause mortality in a population of insurance applicants.
    Clark M; Kaufman V; Fulks M; Dolan VF; Stout RL
    J Insur Med; 2014; 44(1):7-16. PubMed ID: 25004594
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progression of mean age and mean expected mortality rate by duration of follow up in cohorts with a wide range of age.
    Singer RB
    J Insur Med; 2006; 38(3):181-91. PubMed ID: 17076138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Albumin and all-cause mortality risk in insurance applicants.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2010; 42(1):11-7. PubMed ID: 21290995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Questionnaire based mortality assessment: an exploratory analysis of NHANES III.
    Bloom T; Krause KJ
    J Insur Med; 2012; 43(1):10-7. PubMed ID: 22397126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of a mean entry age underestimates expected mean mortality rate.
    Singer RB
    J Insur Med; 2006; 38(2):94-104. PubMed ID: 16845842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structured settlement annuities, part 2: mortality experience 1967--95 and the estimation of life expectancy in the presence of excess mortality.
    Singer RB; Schmidt CJ
    J Insur Med; 2000; 32(3):137-54. PubMed ID: 15912914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of policies on insured lives with elevated blood pressure known at time of issue.
    Woodman H; Mast J; Milano A; Ingle D; Bergstrom R; Hart A; Hoffman NJ
    J Insur Med; 2003; 35(2):72-84. PubMed ID: 14733030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Scoring life insurance applicants' laboratory results, blood pressure and build to predict all-cause mortality risk.
    Fulks M; Stout RL; Dolan VF
    J Insur Med; 2012; 43(3):169-77. PubMed ID: 23451618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.